Monthey Resident

Novochizol SA

Researches and develops applications of Novochizol, a unique chitosan nanoparticle technology that yields different carriers of small molecules, peptides, nucleic acids and proteins for sustained, localized delivery to any living tissue, with intracellular targeting potential.

Orio Therapeutics

Orio Therapeutics is developing an innovative technology that modifies therapeutic proteins to improve delivery through controlled localization for increased efficacy and reduced dose. Today, Orio Therapeutics is focused on developing therapies for patients with myocardial infarction. However, it remains capable of modifying any protein-based therapy with its technology

Sunchemical

Monthey is home to the production of high performance organic pigments. The pigments are used for colouring paints, plastics, inks, synthetic fibres, as well as in electronic applications such as colour filters for liquid crystal displays.

AlphaOnco Swiss SA

AlphaOnco Swiss, subsidiary of Nanobacterie, is developing a cancer treatment using natural iron oxide nano-minerals, called magnetosomes, which are introduced to tumors and heated using various excitation sources (laser, ultrasound, magnetic field).

ASSCO Engineering Monthey SA

As a neutral, independent partner, ASSCO Engineering plans and realizes pharmaceutical and/or sterile production facilities in compliance with GMP guidelines and the requirements of inspection bodies active in the pharmaceutical and medical industries.

Scroll to Top